Oxycodone Hydrochloride Oral Solution
NDC Package 13107-261-58
Package Information
Oxycodone Hydrochloride Oral Solution solution is oxycodone Hydrochloride Oral Solution is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. This formulation utilizes a solution delivery system. Marketed by Aurolife Pharma, Llc, this product is identified by NDC 13107-261 and is authorized under FDA application ANDA212429.
Identification & Billing
- RxCUI: 1049604 - oxyCODONE HCl 5 MG in 5 mL Oral Solution
- RxCUI: 1049604 - oxycodone hydrochloride 1 MG/ML Oral Solution
- RxCUI: 1049604 - oxycodone hydrochloride 5 MG per 5 ML Oral Solution
- RxCUI: 1049615 - oxyCODONE HCl 20 MG in 1 mL Concentrate for Oral Solution
- RxCUI: 1049615 - oxycodone hydrochloride 20 MG/ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 13107 - Aurolife Pharma, Llc
- 13107-261 - Oxycodone Hydrochloride Oral Solution
- 13107-261-58 - 1 BOTTLE in 1 CARTON / 500 mL in 1 BOTTLE
- 13107-261 - Oxycodone Hydrochloride Oral Solution
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 13107-261-58 identifies a specific commercial package of 1 bottle in 1 carton / 500 ml in 1 bottle of Oxycodone Hydrochloride Oral Solution, a human prescription drug labeled by Aurolife Pharma, Llc. This solution is formulated for oral use and contains oxycodone hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aurolife Pharma, Llc on January 27, 2020. The current certification is valid through December 31, 2026.
How is this Aurolife Pharma, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 13107026158. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.